Pilot Bio, a pioneering domestic synthetic biology company, has successfully concluded a fresh funding round exceeding 100 million yuan. This round was co-led by investors including CICC Capital, Xingxiang Capital, Caixin Capital, and Jiashan Industrial. The infused capital will primarily focus on accelerating the commercialization of novel products and expanding Pilot Bio's footprint into global markets.

Leveraging its advanced AI-powered synthetic biotechnology platform, Pilot Bio has cultivated several proprietary technologies that boast international competitiveness. This robust technological foundation has enabled the company to establish a diverse and innovative product portfolio. Moving forward, Pilot Bio aims to further enhance its "R&D-Production-Supply" ecosystem, expedite the launch of new products, and commit to providing the world with economical and eco-friendly biomanufacturing solutions.